Citations

Showing 10 of 107966 citations.

Imaging assessment after percutaneous left atrial appendage closure: from immediate to long-term follow-up
Cepas‐Guillén, Pedro , Holmes, David R. , Freixa, Xavier, O’Hara, Gilles , Beaudoin, Jonathan , Labbé, Benoît, Rodés‐Cabau, Josep , Salaün, Erwan , O'Hara, Gilles , Beaudoin, Jonathan , Salaun, Erwan , Cepas-Guillen, Pedro , Holmes, David R. , Cavalcante, João L. , Freixa, Xavier, Farjat-Pasos, Julio Iván

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | March 5, 2025 | Volume: 26 | Issue: 6 | Pages: 993-1006

10.1093/ehjci/jeaf078 | PMID 40037694 Get It

Abstract Growing evidence has demonstrated the clinical benefit of percutaneous left atrial appendage closure (LAAC) in patients with atrial fibrillation. Although procedural complication rates have declined with increasing experience, post-procedural device-related complications persist, impacting prognosis and reducing the long-term benefits of the procedure. Given the potential impact of these complications, surveillance imaging after LAAC is mandatory. Currently, different imaging modalities offer unique advantages to manage these complications which warrant a combined approach to optimize both short- and long-term follow-up. The aims of this review are to explore the distinct characteristics of each imaging modality, highlighting the primary findings to be assessed during follow-up imaging. Additionally, we propose an optimized clinical imaging surveillance roadmap from discharge to long-term follow-up.
Time-restricted eating and autosomal dominant polycystic kidney disease: a pilot, randomized clinical trial
Steele, Cortney , Ostrow, Anna, Coleman, Erin R., George, Diana, Bing, Kristen , Ramanathan, Sumana, Gregory, Adriana , Kline, Timothy L. , Thomas, Elizabeth A. , Chonchol, Michel , Nowak, Kristen L. , Nowak, Kristen L , Wang, Wei Qiang , Gitomer, Berenice Y , Thomas, Elizabeth

Mayo Clinic

Clinical Kidney Journal | March 5, 2025 | Volume: 18 | Issue: 4 | Pages: No page available

10.1093/ckj/sfaf069 | PMID 40207097 Get It

ABSTRACT Background Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly inherited progressive kidney disease. Time-restricted eating (TRE) is a fasting regimen that restricts eating to a particular window (typically 8 hours/day), which could slow cyst growth based on preclinical models. Methods A 12-month, randomized, controlled, behavioral dietary intervention compared TRE with a control group given healthy eating advice without TRE (HE), without caloric restriction. Participants underwent baseline and 12-month measurements, including adherence (percentage of participants adhering to the 8-hour window; primary outcome), and MRI to determine height-adjusted total kidney volume (htTKV) and adiposity. Results Twenty-nine participants (23 females, mean standard ± deviation 48 ± 9 years) with a body mass index of 31.1±5 kg/m2 were randomized to TRE (n = 14) or HE (n = 15). Of the total participants, 71% (n = 10) of TRE and 87% (n = 13) of HE participants completed the intervention. The eating window was 9.6 ± 3.6 hours for TRE (60% achieving the 8-hour window) and 12.0 ± 2.0 for HE groups (P = .07). At month 12, both groups lost modest weight (−2.4 ± 6.4% and −3.6 ± 5.4% in the TRE and HE groups, respectively). Annual change in htTKV was 3.0 ± 8.5% and 4.6 ± 8.8% in the TRE and HE groups, respectively. Both change in weight (r = 0.67, P < .01) and change in visceral adiposity (r = 0.54, P < .01) were positively correlated with change in htTKV. Conclusion Both the TRE and HE group lost modest weight at 12 months. The targeted TRE adherence of ≥75% of participants was not achieved. Weight and adiposity loss may be more important drivers of kidney growth than the timing of eating.
Pharmacogenetic Analysis of CYP2C19 for Clopidogrel: Ready for Prime Time
Miller, Joshua R. , Baudhuin, Linnea M. , Miller, Joshua R

Mayo Clinic

Clinical Chemistry | March 4, 2025 | Volume: 71 | Issue: 3 | Pages: 432-433

10.1093/clinchem/hvae203 | PMID 40037408 Get It

Patient with a New Small IgG Kappa Monoclonal Protein
Ianosi-Irimie, Monica, Willrich, Maria Alice V. , Edmonston, Tina Bocker , Willrich, Maria A

Mayo Clinic

Clinical Chemistry | March 4, 2025 | Volume: 71 | Issue: 3 | Pages: 430-431

10.1093/clinchem/hvae152 | PMID 40037406 Get It

Tracing Cellular Senescence in Bone: Time‐Dependent Changes in Osteocyte Cytoskeleton Mechanics and Morphology
Tilton, Maryam , Liao, Junhan, Kim, Chanul , Shaygani, Hossein , Potes, Maria Astudillo , Cordova, Domenic J., Kirkland, James L. , Miller, Kyle M. , Tilton, Maryam

Mayo Clinic

Small | March 4, 2025 | Volume: 21 | Issue: 14 | Pages: No page available

10.1002/smll.202408517 | PMID 40026102 Get It

Abstract Aging‐related bone loss significantly impacts the growing elderly population globally, leading to debilitating conditions such as osteoporosis. Senescent osteocytes play a crucial role in the aging process of bone. This longitudinal study examines the impact of continuous local and paracrine exposure to senescence‐associated secretory phenotype (SASP) factors on biophysical and biomolecular markers in osteocytes. Significant cytoskeletal stiffening in irradiated (IR) osteocytes are found, accompanied by expansion of F‐actin areas and a decline in dendritic integrity. These changes, correlating with alterations in pro‐inflammatory cytokine levels and osteocyte‐specific gene expression, support the reliability of biophysical markers for identifying senescent osteocytes. Notably, local accumulation of SASP factors have a more pronounced impact on osteocyte biophysical properties than paracrine effects, suggesting that the interplay between local and paracrine exposure can substantially influence cellular aging. This study underscores the importance of osteocyte mechanical and morphological properties as biophysical markers of senescence, highlighting their time dependence and differential effects of local and paracrine SASP exposure. Collectively, the investigation into biophysical senescence markers offers unique and reliable functional hallmarks for the non‐invasive identification of senescent osteocytes, providing insights that can inform therapeutic strategies to mitigate aging‐related bone loss.
Investigation of Patient With Monoclonal Gammopathy of Thrombotic Significance Unmasks New Type of Platelet-Activating Anti-Platelet Factor 4 Antibody
Kanack, Adam J. , Shah, Surbhi , Padmanabhan, Anand

Mayo Clinic

The Hematologist | March 4, 2025 | Volume: 22 | Issue: 2 | Pages: No page available

10.1182/hem.v22.2.2025213 Get It

Environmental impact of colorectal cancer screening with colonoscopy and multi-target stool DNA (mt-sDNA) testing
Alcock, Rebecca , Kisiel, John B. , Hernandez, Lyndon V. , Delarmente, Benjo A. , Estes, Chris , Bartels, J, Lester, J.F. , Vahdat, Vahab , Limburg, Paul J. , Fendrick, A. Mark , Kisiel, John B , Hernandez, Lyndon V , Delarmente, Benjo A , Estes, Chris , Bartels, Jeff , Vahdat, Vahab , Limburg, Paul J , Fendrick, A Mark , Shaukat, Aasma , Lester, Jason

Mayo Clinic

Health Affairs Scholar | March 4, 2025 | Volume: 3 | Issue: 3 | Pages: No page available

10.1093/haschl/qxaf041 | PMID 40078452 Get It

Abstract The substantial carbon footprint imparted by medical services warrants increased attention to their environmental impact. National guideline organizations such as the US Preventive Services Task Force (USPSTF) recommend multiple modalities for average-risk colorectal cancer (CRC) screening with varying resource intensity. The aim of this study was to quantify the environmental burden for 2 of the most used CRC screening modalities, colonoscopy and the multi-target stool DNA (mt-sDNA) test. A validated CRC microsimulation model was used to estimate the number of screening and follow-up tests for a cohort of 1 million average-risk individuals who underwent screening between ages 45 and 75. Component resources used for mt-sDNA, including waste products, energy, and transportation for colonoscopy and mt-sDNA, were collected from January 1, 2023, to January 1, 2024, and converted to carbon-equivalent emissions. Resources used for colonoscopy were captured from the literature. Resources devoted to screening colonoscopy were substantially (59%) higher than those to mt-sDNA, even when including follow-up colonoscopy. Of note, follow-up colonoscopy accounted for the majority (64%) of total emissions for the mt-sDNA screening strategy. Compared with colonoscopy screening, mt-sDNA substantially reduces the carbon emissions attributable to population-level CRC screening. Environmental impact should be included as a factor when choosing among guideline-recommended CRC screening strategies.
Neurocritical Care
Wijdicks, Eelco F. M. , Rabinstein, Alejandro A.

Mayo Clinic

No container title available | March 4, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/med/9780197676875.001.0001 Get It

Abstract A collection of patients are seen in the neurointensive care unit and other medical and surgical intensive care units. Diagnosis, neuroimaging, and management in acute conditions are discussed in detail. In this new edition, we place more emphasis on how diagnostic and management decisions can go awry. When pertinent, we discuss new care paradigms, the latest support modalities, and new therapies, interventions, and technologies, but the main purpose is to convey a sense of what our specialty is all about. The book is useful for all health care professionals, essential material for learners and fellows in intensive care specialties and informational for staff attending physicians and hospitalists.
Analyzing the Donor Dilemma: Outcomes of Kidney Transplant Recipients From Donors With Positive Blood Cultures Obtained at Organ Procurement
Svoronos, Petros, Acosta, R Alfonso Hernandez , Vijayvargiya, Prakhar , Vaitla, Pradeep , Wynn, J. D. , Parham, Jason, Beam, Elena , Sohail, M. Rizwan , Garrigos, Zerelda Esquer , Hernandez Acosta, R Alfonso , Wynn, James J , Beam, Elena , Sohail, M Rizwan , Esquer Garrigos, Zerelda , Anderson, Christopher D.

Mayo Clinic

Open Forum Infectious Diseases | March 4, 2025 | Volume: 12 | Issue: 2 | Pages: No page available

10.1093/ofid/ofae694 | PMID 40041439 Get It

Abstract Based on expert consensus, the American Society of Transplantation recommends 7–14 days of preventive antibiotic therapy for solid organ transplant recipients from donors with positive blood cultures. We evaluated management and outcomes of kidney transplant recipients from these donors.
Technology Spotlight Use of Mass Spectrometry to Study Antibody Clonality Leads to Identification of Novel Thrombophilia: Monoclonal Gammopathy of Thrombotic Significance
Murray, David , Padmanabhan, Anand

Mayo Clinic

The Hematologist | March 4, 2025 | Volume: 22 | Issue: 2 | Pages: No page available

10.1182/hem.v22.2.2025214 Get It